Aqr Capital Management LLC Biomarin Pharmaceutical Inc Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 598,500 shares of BMRN stock, worth $39.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
598,500
Previous 55,372 980.87%
Holding current value
$39.9 Million
Previous $4.56 Million 822.95%
% of portfolio
0.06%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$69.02 - $93.84 $37.5 Million - $51 Million
543,128 Added 980.87%
598,500 $42.1 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $2.43 Million - $3.02 Million
32,709 Added 144.33%
55,372 $4.56 Million
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $2.88 Million - $3.41 Million
-34,410 Reduced 60.29%
22,663 $1.98 Million
Q4 2023

Feb 14, 2024
SELL
$76.22 - $98.51 $2.44 Million - $3.15 Million
-31,984 Reduced 35.91%
57,073 $5.5 Million
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $7.34 Million - $8.16 Million
-86,329 Reduced 49.22%
89,057 $7.88 Million
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $8.64 Million - $10 Million
99,686 Added 131.69%
175,386 $15.2 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $2.24 Million - $2.99 Million
25,505 Added 50.81%
75,700 $7.36 Million
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $1.71 Million - $2.29 Million
21,108 Added 72.57%
50,195 $5.19 Million
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $1.73 Million - $2.04 Million
21,038 Added 261.37%
29,087 $2.47 Million
Q2 2022

Aug 15, 2022
BUY
$71.48 - $86.85 $138,599 - $168,402
1,939 Added 31.73%
8,049 $663,000
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $282,932 - $353,056
3,809 Added 165.54%
6,110 $471,000
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $75,592 - $96,409
-1,054 Reduced 31.42%
2,301 $203,000
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $523,165 - $598,033
-6,997 Reduced 67.59%
3,355 $259,000
Q2 2021

Aug 16, 2021
BUY
$75.51 - $84.79 $226,605 - $254,454
3,001 Added 40.82%
10,352 $860,000
Q1 2021

May 17, 2021
SELL
$74.73 - $90.69 $1.74 Million - $2.11 Million
-23,264 Reduced 75.99%
7,351 $555,000
Q4 2020

Feb 16, 2021
SELL
$72.61 - $90.2 $5.58 Million - $6.93 Million
-76,861 Reduced 71.51%
30,615 $2.63 Million
Q3 2020

Nov 16, 2020
BUY
$71.87 - $131.03 $6.71 Million - $12.2 Million
93,421 Added 664.68%
107,476 $8.18 Million
Q2 2020

Aug 17, 2020
BUY
$79.55 - $124.22 $544,917 - $850,907
6,850 Added 95.07%
14,055 $1.73 Million
Q1 2020

May 15, 2020
SELL
$71.37 - $96.85 $555,900 - $754,364
-7,789 Reduced 51.95%
7,205 $595,000
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $963,664 - $1.3 Million
14,994 New
14,994 $1.26 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email